There is a close overlap between iNPH and Alzheimer’s disease (AD) as both conditions present with abnormal deposition in the brain of toxic by-products of cerebral metabolism, such as amyloid-beta 1–42 (amyloid-β 1–42) and Tau [42]. This evidence concerns the gene MAPT and Alzheimer disease.